[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-454882-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-454882-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","idiopathic-hyperprolactinemia-clinical-presentation-diagnosis-management-and-clinical-outcome","Idiopathic Hyperprolactinemia - Clinical Presentation, Diagnosis, Management, and Clinical Outcome","","Idiopathic hyperprolactinemia is presented in a 25-year-old woman with established polycystic ovary syndrome (PCOS), highlighting diagnostic overlap between endocrine disorders that can present with menstrual irregularities and metabolic dysfunction. Persistent prolactin elevation was identified through serial laboratory assessments, while pituitary imaging excluded structural abnormalities. Management included lifestyle modification guidance and dopamine agonist therapy with continuous monitoring of hormonal, metabolic, and psychological parameters. The case emphasizes multidisciplinary care and the need for further observation of possible neuropsychiatric effects of prolactin dysregulation.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/idiopathic-hyperprolactinemia-clinical-presentation-diagnosis-management-and-clinical-outcome/454882/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/idiopathic-hyperprolactinemia-clinical-presentation-diagnosis-management-and-clinical-outcome/454882.png","ImageObject",300,407,{"name":42,"@type":43},"Stanford","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-30",true,{"@type":52,"interactionType":53,"userInteractionCount":26},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What symptoms and background were reported in the case of idiopathic hyperprolactinemia?","Question",{"text":62,"@type":63},"A 25-year-old woman with PCOS presented with 10 months of amenorrhea and progressive weight gain. She also reported irregular cycles prior to September 2011.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How was structural pituitary disease evaluated and ruled out?",{"text":67,"@type":63},"Persistently elevated prolactin levels were confirmed and pituitary imaging ruled out structural abnormalities, supporting an idiopathic etiology.",{"name":69,"@type":60,"acceptedAnswer":70},"What treatment approach was used and what was monitored during management?",{"text":71,"@type":63},"Management combined lifestyle modification advice with dopamine agonist therapy. Hormonal, metabolic, and psychological parameters were monitored with continuous follow-up and serial prolactin testing.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},454882,1790741598,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,109,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":107,"slug":108},7,40,"healthcare",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},8,"Research & Report",30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":106,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":26,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":33,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":79,"read_time":123,"preview_page_count":4},2336477552062,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Review began 11/14/2025  \nReview ended 11/23/2025  \nPublished 12/08/2025  \n© Copyright 2025  \nSholuade et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CCBY 4.0. , which permits unrestricted use , distribution , and reproduction in any medium , provided the original author and source are credited.  \nDOI: 10.7759/cureus.98701  \nOpen Access Case Report  \nIdiopathic Hyperprolactinemia: Clinical Presentation, Diagnosis, Management, and Clinical Outcome  \nOlabosipo Sholuade 1, Goodness Njoku 1 , Suma Kaza 2 , Reshma A. Fatteh 3 , Manoj Kollukkad 4 , Charles Edwards 5  \n1. Medical School, Avalon University School of Medicine, Willemstad, CUW 2. Pathology, Avalon University School of Medicine, Willemstad, CUW 3. Behavioral Health and Psychiatry, Avalon University School of Medicine, Willemstad, CUW 4. Human Structure and Function, Avalon University School of Medicine, Willemstad, CUW 5. Obstetrics and Gynecology, Avalon University School of Medicine, Willemstad, CUW  \nCorresponding author: Olabosipo Sholuade, [olabosipo.m1j24@avalonu.org](olabosipo.m1j24@avalonu.org)  \nAbstract  \nPolycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder often presenting with menstrual irregularities, hyperandrogenism, and metabolic dysfunction. Hyperprolactinemia, characterized by elevated prolactin levels, may share overlapping features with PCOS and complicate diagnosis. When these two conditions coexist, they present unique clinical and management challenges.  \nA 25-year-old woman with a history of PCOS presented with amenorrhea, progressive weight gain, and irregular menstrual cycles. Laboratory investigations revealed persistently elevated prolactin levels, while pituitary imaging ruled out structural abnormalities. The patient received lifestyle modification advice and dopamine agonist therapy, with continuous monitoring of hormonal, metabolic, and psychological parameters.  \nThis case highlights the diagnostic complexity of idiopathic hyperprolactinemia occurring in the context of PCOS, and emphasizes the importance of a multidisciplinary approach to management. Further clinical observations are needed to understand the neuropsychiatric effects of prolactin dysregulation.  \nCategories: Obstetrics/Gynecology, Psychiatry, Internal Medicine  \nKeywords: bromocriptine therapy, dopamine agonists, hyperprolactinemia and mood disorders, hyperprolactinemia diagnosis, idiopathic hyperprolactinemia, pcos and hyperprolactinemia, pituitary imaging, prolactin dysregulation  \nIntroduction  \nHyperprolactinemia, defined as elevated serum prolactin levels, is an endocrine disorder that frequently presents with menstrual irregularities, galactorrhea, and infertility [1,2] . It is most commonly caused by pituitary adenomas (prolactinomas) but may also result from medications, hypothyroidism, or stress [2,3] .  \nThe diagnosis of hyperprolactinemia requires careful evaluation to determine potential etiologies and to exclude structural causes [1,2] . Importantly, elevated prolactin levels have been associated with mood disturbances, including anxiety and depressive symptoms, likely due to their influence on serotonin and dopamine pathways [4,5] . Several systematic reviews and meta-analyses support a relationship between hyperprolactinemia and neuropsychiatric manifestations. However, the strength of this association may vary and should be considered on a case-by-case basis [4,5] .  \nThis case report explores the diagnostic challenges and therapeutic approach in a patient presenting with idiopathic hyperprolactinemia while discussing the potential implications of prolactin dysregulation on mood disorders as a possible, but not definitive, clinical manifestation. Although mood disturbances are highlighted in current literature, the patient did not endorse any such symptoms during evaluation,  \nunderscoring the heterogeneity in clinical presentation.  \nCase Presentation  \nA 25-year-old female w","cbCaicbjUvlwv8sI","https://ap.wps.com/l/cbCaicbjUvlwv8sI","pdf",113577,"English","# Introduction\n# Case Presentation\n# Laboratory findings\n## How to cite this article","[{\"question\":\"What symptoms and background were reported in the case of idiopathic hyperprolactinemia?\",\"answer\":\"A 25-year-old woman with PCOS presented with 10 months of amenorrhea and progressive weight gain. She also reported irregular cycles prior to September 2011.\"},{\"question\":\"How was structural pituitary disease evaluated and ruled out?\",\"answer\":\"Persistently elevated prolactin levels were confirmed and pituitary imaging ruled out structural abnormalities, supporting an idiopathic etiology.\"},{\"question\":\"What treatment approach was used and what was monitored during management?\",\"answer\":\"Management combined lifestyle modification advice with dopamine agonist therapy. Hormonal, metabolic, and psychological parameters were monitored with continuous follow-up and serial prolactin testing.\"}]","Idiopathic Hyperprolactinemia - Clinical Presentation, Diagnosis, Management, and Clinical Outcome | PDF"]